Weaver Gregory L's Form 4 filing
Altimmune, Inc. (ALT) · filed Aug 3, 2026
- Accession no.
- 0001251779-26-000009
- Filed
- Aug 3, 2026, 4:05 PM ET
- Trade date
- Jul 31, 2026
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Weaver Gregory LCIK 0001251779 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 31, 2026 | Common Stock, par value $0.0001 | AGrant or awardAcquired | +1,753 | $2.41F2 | +$4,231.74 | 39,831 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on July 31, 2026.
Referenced by the price of 1 transaction in Table I.